The UT Austin Daily Texan has the only report that I can find in the news about Wednesday’s announcement that the University of Texas Health Center in Houston is the recipient of $17.9 million for stem cell research on treatments for heart disease.
The National Heart Lung and Blood Institute granted $17.9 million for the research of stem-cell treatments for cardiovascular disease to the UT School of Public Health Coordinated Center for Clinical Trials.
The school was established in 1967 as part of the UT Health Science Center in Houston.
The new funding will bring the institution to the forefront of stem-cell, cardiovascular research. Charged with coordinating the network’s participating centers, the school will serve as the hub for the Cardiovascular Cell Therapy Research Network.
“This research will examine the promise of approved stem-cell research of cardiovascular disease,” Dr. Lemuel A. Moye said.
The network’s centers include the University of Florida, the Cleveland Clinic, the University of Minnesota, the Texas Heart Institute and Vanderbilt University. Dr. Lemuel A. Moye, biostatistics professor and principal investigator of the program at the UT School of Public Health, was excited that the institution was selected to coordinate the other centers.
“It was a pleasant surprise,” he said.
I wonder whether this grant will help one of the Houston Health Center Hospitals begin collecting cord blood?
Or will the docs at the UT School of Public Health work with Dr. Willerson and Dr. Perin at the Texas Heart Institute, who are testing a system to select progenitor cells to repair heart tissue, using a commercial product, Aldagen?
Hopefully there’s a coordinating board somewhere that’s watching over the efficiency of these different research groups.